Skip to content

AIA Trial Institution Rates Are Good News For Patent Owners | Law360

AIA Trial Institution Rates Are Good News For Patent Owners | Law360 Headshot

Nathanael Luman, Ph.D.

Nathanael R. Luman, Ph.D., represents chemical and pharmaceutical companies in intellectual property matters. He is actively involved in Inter Partes Review (IPR) proceedings before the Patent Trial and Appeal Board....